Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
272 |
|
| Actual shortage: | 6 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 14 (5%) | |
| Resolved: | 251 (92%) | |
Discontinuation Reports |
49 |
|
| To be discontinued: | 5 (10%) | |
| Discontinued: | 44 (90%) | |
| Reversed: | 0 (0%) | |
Late reports |
20 (6%) |
|
Overdue reports |
4 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PRALUENT | 75MG | SOLUTION | Resolved | 2021-10-29 | 2021-11-09 | 148536 |
| PRALUENT | 75MG | SOLUTION | Resolved | 2023-01-13 | 2023-02-03 | 181002 |
| PRALUENT | 75MG | SOLUTION | Resolved | 2023-11-07 | 2024-01-02 | 209523 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2019-01-25 | 2019-02-27 | 73630 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2019-04-02 | 2019-05-10 | 80308 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2021-04-09 | 2021-05-04 | 137220 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2022-11-29 | 2022-12-23 | 176325 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-01-17 | 2023-01-30 | 181300 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-05-17 | 2023-06-01 | 192669 |
| PRALUENT | 150MG | SOLUTION | Resolved | 2023-11-07 | 2024-01-02 | 209520 |
| PLAVIX | 75MG | TABLET | Resolved | 2018-11-29 | 2019-01-25 | 68065 |
| PLAVIX | 75MG | TABLET | Resolved | 2019-06-19 | 2019-08-12 | 87048 |
| PLAVIX | 75MG | TABLET | Resolved | 2022-07-19 | 2022-09-14 | 165000 |
| PLAVIX | 75MG | TABLET | Resolved | 2022-09-13 | 2023-01-18 | 169210 |
| PLAVIX | 75MG | TABLET | Resolved | 2023-02-10 | 2023-02-15 | 184405 |
| PLAVIX | 75MG | TABLET | Resolved | 2023-06-07 | 2023-09-16 | 193873 |
| PLAVIX | 75MG | TABLET | Resolved | 2023-09-28 | 2023-12-12 | 205398 |
| PLAQUENIL | 200MG | TABLET | Resolved | 2018-09-26 | 2018-10-04 | 62418 |
| PLAQUENIL | 200MG | TABLET | Resolved | 2021-12-06 | 2022-01-07 | 150486 |
| PLAQUENIL | 200MG | TABLET | Resolved | 2022-04-22 | 2022-08-01 | 159313 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| DIABETA | 5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100938 |
| DEMEROL | 50MG | TABLET | Discontinued | 2019-11-11 | 2020-07-29 | 98380 |
| CONDYLINE | 0.5% | SOLUTION | To be discontinued | 2021-07-13 | 2021-07-13 | 142368 |
| CLOMID | 50MG | TABLET | Discontinued | 2017-03-22 | 2017-03-22 | 3917 |
| CLAFORAN - PWS INJ 2.0G/VIAL | 2G | POWDER FOR SOLUTION | Discontinued | 2017-03-20 | 2017-04-05 | 3685 |
| CLAFORAN - PWS INJ 1.0G/VIAL | 1G | POWDER FOR SOLUTION | Discontinued | 2017-03-16 | 2017-05-02 | 3103 |